GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan · Delayed Price · Currency is TWD 16.35
-0.30 (-1.80%)
Oct 30, 2026, 1:30 PM CST
GeneReach Biotechnology Market Cap
GeneReach Biotechnology has a market cap or net worth of 938.16 million as of October 30, 2026. It is the 34,223rd most valuable company in the world and the 2,066th biggest in Taiwan. Its market cap has decreased by 37.57% in one year.
Market Cap
938.16M
Enterprise Value
867.45M
Revenue
238.08M
Global Rank
Country Rank
#2,066 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 938.16M, a decrease of -26.28%. That is a compound annual growth rate of -2.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 938.16M | -13.52% |
| Dec 31, 2025 | 1.08B | -34.10% |
| Dec 31, 2024 | 1.65B | -27.38% |
| Dec 29, 2023 | 2.27B | -25.28% |
| Dec 30, 2022 | 3.03B | -20.04% |
| Dec 30, 2021 | 3.79B | -27.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.22B |
| Bio Preventive Medicine | 1.14B |
| Enimmune | 1.13B |
| LabTurbo Biotech | 1.11B |
| Level Biotechnology | 993.06M |
| BiOptic | 992.66M |
| Holy Stone Healthcare | 966.35M |
| TCI GENE | 952.51M |